A DNA/HDAC dual‐targeting drug CY190602 with significantly enhanced anticancer potency
Abstract Genotoxic drugs constitute a major treatment modality for human cancers; however, cancer cells' intrinsic DNA repair capability often increases the threshold of lethality and renders these drugs ineffective. The emerging roles of HDACs in DNA repair provide new opportunities for improv...
Saved in:
| Main Authors: | Chuan Liu, Hongyu Ding, Xiaoxi Li, Christian P Pallasch, Liya Hong, Dianwu Guo, Yi Chen, Difei Wang, Wei Wang, Yajie Wang, Michael T Hemann, Hai Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2015-03-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201404580 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation
by: Ching Lin, et al.
Published: (2025-12-01) -
Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications
by: Saooda Ibrahim, et al.
Published: (2025-03-01) -
Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases
by: Maria A. Theodoropoulou, et al.
Published: (2024-12-01) -
HDAC1 and HDAC2 Are Involved in Influenza A Virus-Induced Nuclear Translocation of Ectopically Expressed STAT3-GFP
by: Jessica Leong, et al.
Published: (2024-12-01) -
Butyrate Prevents Obesity Accompanied by HDAC9-Mediated Browning of White Adipose Tissue
by: Jing Yang, et al.
Published: (2025-01-01)